ArticleOncotarget2015

Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.

Seth A Brodie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.